Qiang Chen

Biodesign Center for Immunotherapy, Vaccines, and Virotherapy

Location: TEMPE

Contact Information
(480) 965-8110


Ph.D. University of Arizona


West Nile Therapeutics project

Dr. Qiang "Shawn" Chen is a faculty member at the Center for Infectious Diseases and Vaccinology in the Biodesign Institute of ASU and at ASU's School of Life Sciences.

His research focuses on two areas of basic plant biology: gene expression and protein trafficking. The Chen Laboratory is interested in how gene expression is controlled in plants at the transcriptional and post-transcriptional levels as well as to identify and characterize new genetic elements that control gene expression. Another area of interest is to understand the regulation and mechanism of protein post-translational modification and assembly. 

The Chen Laboratory also wants to apply the knowledge learned in the above basic research area to plant biotechnology, specifically, to develop novel human biologics. His laboratory is interested primarily in optimizing the expression and assembly of monoclonal antibodies (mAbs) and in designing novel mAb fusion proteins to enhance their targeting and efficacy (e. g., West Nile Therapeutics project). Another area of his research is protein chemistry. His laboratory is intent on developing innovative protein separation technologies for processing human therapeutics from plants. In his capacity as the Director of ASUâs Laboratory for Plant Biotechnology and Pharmaceutical Research, he is interested in mentoring scientists and students to perform protein chemistry under FDAâs current Good Manufacture Practice regulations. 

He was a PMGI and NIH postdoctoral fellow at University of Minnesota. Dr. Chen spent more than 10 years in the biotechnology and pharmaceutical industry directing molecular biology and biochemistry research in both plant and mammalian cell culture systems.  Prior to joining ASU, he was the director of Division of Protein Chemistry at Cardinal Health.